Tryptamine Therapeutics Limited (ASX:TYP)

Tryptamine Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	5.37	0.44	2.02	3.93	1.06
Cash & Short-Term Investments	5.37	0.44	2.02	3.93	1.06
Cash Growth	1112.68%	-78.04%	-48.73%	271.83%	-
Other Receivables	1.4	0.07	0.01	0.02	-
Receivables	1.4	0.07	0.01	0.02	-
Prepaid Expenses	0.31	0.04	0.32	0.4	0.03
Restricted Cash	-	-	0.08	0.06	-
Total Current Assets	7.08	0.55	2.42	4.42	1.09
Other Intangible Assets	0.37	0.2	0.18	0.03	1
Long-Term Deferred Charges	-	-	-	-	0.03
Other Long-Term Assets	0	-	-	-	-
Total Assets	7.45	0.75	2.6	4.45	2.11
Accounts Payable	1.27	2.09	1.28	0.2	0.15
Accrued Expenses	0.36	0.15	0.05	0	0.04
Short-Term Debt	0.2	-	-	-	0
Other Current Liabilities	0	0.01	-	-	0.01
Total Current Liabilities	1.83	2.25	1.33	0.2	0.2
Long-Term Debt	-	2.4	-	-	-
Other Long-Term Liabilities	-	0.39	-	-	-
Total Liabilities	1.83	5.04	1.33	0.2	0.2
Common Stock	29.91	15.09	15.03	10.49	2.35
Additional Paid-In Capital	-	-	3.52	3.15	-
Retained Earnings	-30.07	-23.93	-18.01	-9.39	-0.44
Comprehensive Income & Other	5.78	4.55	0.73	-	-
Shareholders' Equity	5.62	-4.29	1.27	4.25	1.91
Total Liabilities & Equity	7.45	0.75	2.6	4.45	2.11
Total Debt	0.2	2.4	-	-	0
Net Cash (Debt)	5.17	-1.96	2.02	3.93	1.05
Net Cash Growth	-	-	-48.73%	273.49%	-
Net Cash Per Share	0.01	-0.01	0.03	0.08	-
Filing Date Shares Outstanding	1,139	93.38	87.29	51.45	18.1
Total Common Shares Outstanding	1,139	93.38	87.29	51.45	18.1
Working Capital	5.25	-1.7	1.09	4.22	0.89
Book Value Per Share	0.00	-0.05	0.01	0.08	0.11
Tangible Book Value	5.25	-4.49	1.09	4.22	0.92
Tangible Book Value Per Share	0.00	-0.05	0.01	0.08	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.